Elon Musk has done it again. His brain-chip company Neuralink just raised $600 million at a $9 billion valuation, marking a ...

Abstracts related to the EACR meeting will be published online following the presentation. For more information, please visit the EACR 2025 website. Purple Biotech Ltd. (NASDAQ/TASE: PPBT ...

CHICAGO, May 15, 2025--(BUSINESS WIRE)--MAIA Biotechnology ... the Phase 2 THIO-101 clinical trial was accepted for poster presentation at the 2025 Annual Meeting of the American Society of ...

Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. The Company's oncology pipeline ...

MAIA Biotechnology, Inc. (NYSE American ... data from the Phase 2 THIO-101 clinical trial was accepted for poster presentation at the 2025 Annual Meeting of the American Society of Clinical ...

Abstracts related to the EACR meeting will be published online following the presentation. For more information, please visit the EACR 2025 website. Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a ...

Company to present interim update from ENLIGHTED Phase 3 Study in LG UTUC following assessment of 50% of targeted total evaluable patient enrollment -- TEL AVIV, Israel, May 22, 2025 (GLOBE NEWSWIRE) ...

About MAIA Biotechnology, Inc. MAIA is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of ...

Nvidia Corporation NVDA CEO Jensen Huang’s rejection of PowerPoint presentations isn't a quirky habit—it's part of a broader trend among some of the most successful tech leaders who believe ...